ALVO
Alvotech
Catalyst
AI-extracted
AVT16
proposed interchangeable biosimilar to Entyvio (vedolizumab) for intravenous administration
29d ago
Jun 8, 2026
SEC 6-K
verified 12h ago
Countdown card →